Novel Compound LASSS Identified to 'Supercharge' Muscle Repair and Combat Sarcopenia

When older adults begin to lose muscle mass, the common assumption is that the body has simply stopped producing the raw materials needed for strength. But new evidence suggests the machinery is still there—it is just receiving a garbled signal. Researchers at Kyushu University have identified a sulfur-based compound, lipoic acid trisulfide (LASSS), that protects and enhances a critical muscle-repair protein. Published in Scientific Reports, the findings offer a novel approach to combating sarcopenia by fixing the body's existing communication network rather than trying to replace it.[3][7]

Skeletal muscle naturally deteriorates with age, leading to weakness, fat accumulation, and a decline in the fast-twitch fibers necessary for quick, powerful movements. This decline is largely driven by the failure of the body's internal repair signaling. Hepatocyte growth factor (HGF) normally acts as a wake-up call for muscle stem cells, known as satellite cells, instructing them to multiply and rebuild damaged tissue after injury or mechanical stress.[3][5]

As the body ages, HGF undergoes a chemical alteration called nitration. Nitro groups attach to specific tyrosine sites on the protein, distorting the region it uses to dock with its c-Met receptor on satellite cells. Like a rusted key that no longer fits its lock, the nitrated HGF fails to activate the stem cells, leaving the muscle unable to repair itself effectively even when the necessary cells are present.[1][3]

To counter this interference, the Kyushu University team tested sulfur-rich antioxidant molecules capable of modulating protein chemistry. They found that exposing HGF to LASSS not only suppressed the inhibitory nitration but also induced a structural modification in the protein itself. This interaction created what researchers termed a "Super HGF" state, which proved highly resistant to the oxidative damage that typically shuts down muscle repair in older adults.[1][6]

The most striking result occurred when researchers increased the concentration of LASSS. The compound did more than just neutralize reactive molecules; the treated HGF demonstrated more than double the normal binding affinity for the c-Met receptor compared to untreated, non-damaged HGF. A similar compound tested in the study, glutathione trisulfide (GSSSG), failed to produce this enhancement, highlighting the unique structural benefits of LASSS.[2][4]

To verify that these laboratory results translate to living tissue, the researchers tested LASSS in a mouse model of muscle atrophy caused by hind-limb suspension—a method used to simulate prolonged bed rest or disuse. Mice pretreated with LASSS showed significantly reduced HGF nitration and preserved muscle repair signaling compared to untreated animals, confirming that the compound's protective effects carry over into complex biological systems.[1][3]

Because the molecular structure of HGF and its signaling pathways are highly conserved across mammalian species, the researchers believe this therapeutic approach holds significant translational promise for humans. Rather than relying on artificial muscle enhancers or hormone therapies, this method targets the precise chemical modification that disables endogenous repair signals, effectively restoring the body's natural regenerative capacity.[5][6]

For readers looking to apply this science today, the practical takeaway requires patience. The research remains in the preclinical stage, and ordinary lipoic acid supplements currently on the market do not produce the same "Super HGF" effect. Until human trials confirm optimal dosing and long-term safety, the most proven method for combating sarcopenia remains consistent resistance training and adequate protein intake to mechanically stimulate whatever HGF signaling remains intact.[4][5]